The gut microbiome plays an important role in human health and influences the
development of chronic diseases ranging from metabolic disease to gastrointestinal …

Small intestinal bacterial overgrowth (SIBO) is one manifestation of gut microbiome
dysbiosis and is highly prevalent in IBS (Irritable Bowel Syndrome). SIBO can be diagnosed …

Background Changes in diet and exercise can alter the gut microbiome of humans and
mice; however, few studies to date have assessed the microbiomes of highly fit athletes. In …

Background & Aims The existence of postinfection irritable bowel syndrome (PI-IBS) has
been substantiated by epidemiology studies conducted in diverse geographic and clinical …

The human gastrointestinal tract harbors most of the microbial cells inhabiting the body,
collectively known as the microbiota. These microbes have several implications for the …

Hydrogen plays a key role in many microbial metabolic pathways in the human
gastrointestinal tract (GIT) that have an impact on human nutrition, health and wellbeing …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with the
pathological accumulation of lipids inside hepatocytes. Untreated NAFL can progress to non …

Irritable bowel syndrome (IBS) is one of the most prevalent functional gastrointestinal
disorders, and accumulating evidence gained in both preclinical and clinical studies indicate …

We report the first use of constraint-based microbial community modeling on a single
individual with episodic inflammation of the gastrointestinal tract, who has a well …

Background and Aims The composition of the human gut microbiota is linked to health and
disease, and knowledge of the impact of therapeutics on the microbiota is essential to …